These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 17875732)

  • 1. Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma.
    Kryczek I; Wei S; Zhu G; Myers L; Mottram P; Cheng P; Chen L; Coukos G; Zou W
    Cancer Res; 2007 Sep; 67(18):8900-5. PubMed ID: 17875732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration.
    Miyatake T; Tringler B; Liu W; Liu SH; Papkoff J; Enomoto T; Torkko KC; Dehn DL; Swisher A; Shroyer KR
    Gynecol Oncol; 2007 Jul; 106(1):119-27. PubMed ID: 17509674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma.
    Wei S; Kryczek I; Edwards RP; Zou L; Szeliga W; Banerjee M; Cost M; Cheng P; Chang A; Redman B; Herberman RB; Zou W
    Cancer Res; 2007 Aug; 67(15):7487-94. PubMed ID: 17671219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cells.
    Leveque L; Deknuydt F; Bioley G; Old LJ; Matsuzaki J; Odunsi K; Ayyoub M; Valmori D
    J Immunother; 2009; 32(2):101-8. PubMed ID: 19238008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the subpopulation of CD25+ CD4+ and FOXP3+ regulatory T cells in decidua with respect to the progression of labor at term and the lack of analogical changes in the subpopulation of suppressive B7-H4 macrophages--a preliminary report.
    Galazka K; Wicherek L; Pitynski K; Kijowski J; Zajac K; Bednarek W; Dutsch-Wicherek M; Rytlewski K; Kalinka J; Basta A; Majka M
    Am J Reprod Immunol; 2009 Feb; 61(2):136-46. PubMed ID: 19143677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells.
    Kryczek I; Wei S; Zou L; Zhu G; Mottram P; Xu H; Chen L; Zou W
    J Immunol; 2006 Jul; 177(1):40-4. PubMed ID: 16785496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression.
    Simon I; Katsaros D; Rigault de la Longrais I; Massobrio M; Scorilas A; Kim NW; Sarno MJ; Wolfert RL; Diamandis EP
    Gynecol Oncol; 2007 Aug; 106(2):334-41. PubMed ID: 17498784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells.
    Parietti V; Monneaux F; Décossas M; Muller S
    Arthritis Rheum; 2008 Jun; 58(6):1751-61. PubMed ID: 18512811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of human T-cell responses to beta-cells by activation of B7-H4 pathway.
    Ou D; Wang X; Metzger DL; Ao Z; Pozzilli P; James RF; Chen L; Warnock GL
    Cell Transplant; 2006; 15(5):399-410. PubMed ID: 16970282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced expression of B7-H4 on the surface of lung cancer cell by the tumor-associated macrophages: a potential mechanism of immune escape.
    Chen C; Qu QX; Shen Y; Mu CY; Zhu YB; Zhang XG; Huang JA
    Cancer Lett; 2012 Apr; 317(1):99-105. PubMed ID: 22108530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B7-H4 transfection prolongs beta-cell graft survival.
    Yuan CL; Xu JF; Tong J; Yang H; He FR; Gong Q; Xiong P; Duan L; Fang M; Tan Z; Xu Y; Chen YF; Zheng F; Gong FL
    Transpl Immunol; 2009 Jul; 21(3):143-9. PubMed ID: 19361556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells.
    Yang R; Cai Z; Zhang Y; Yutzy WH; Roby KF; Roden RB
    Cancer Res; 2006 Jul; 66(13):6807-15. PubMed ID: 16818658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.
    Kiniwa Y; Miyahara Y; Wang HY; Peng W; Peng G; Wheeler TM; Thompson TC; Old LJ; Wang RF
    Clin Cancer Res; 2007 Dec; 13(23):6947-58. PubMed ID: 18056169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
    Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
    Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B7-H1 up-regulation on dendritic-like leukemia cells suppresses T cell immune function through modulation of IL-10/IL-12 production and generation of Treg cells.
    Ge W; Ma X; Li X; Wang Y; Li C; Meng H; Liu X; Yu Z; You S; Qiu L
    Leuk Res; 2009 Jul; 33(7):948-57. PubMed ID: 19233469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B7-H3 and B7-H4 expression in non-small-cell lung cancer.
    Sun Y; Wang Y; Zhao J; Gu M; Giscombe R; Lefvert AK; Wang X
    Lung Cancer; 2006 Aug; 53(2):143-51. PubMed ID: 16782226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presence of B7-H4+ macrophages and CD25+CD4+ and FOXP3+ regulatory T cells in the microenvironment of nasal polyps - a preliminary report.
    Dutsch-Wicherek M; Tomaszewska R; Lazar A; Strek P; Wicherek L; Kijowski J; Majka M
    Folia Histochem Cytobiol; 2010 Dec; 48(4):611-7. PubMed ID: 21478105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse Sertoli cells display phenotypical and functional traits of antigen-presenting cells in response to interferon gamma.
    Dal Secco V; Riccioli A; Padula F; Ziparo E; Filippini A
    Biol Reprod; 2008 Feb; 78(2):234-42. PubMed ID: 17989360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma.
    Kryczek I; Zou L; Rodriguez P; Zhu G; Wei S; Mottram P; Brumlik M; Cheng P; Curiel T; Myers L; Lackner A; Alvarez X; Ochoa A; Chen L; Zou W
    J Exp Med; 2006 Apr; 203(4):871-81. PubMed ID: 16606666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity.
    Giuntoli RL; Webb TJ; Zoso A; Rogers O; Diaz-Montes TP; Bristow RE; Oelke M
    Anticancer Res; 2009 Aug; 29(8):2875-84. PubMed ID: 19661290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.